Cost–utility analysis - PDFSEARCH.IO - Document Search Engine

Cost–utility analysis
Results: 159

#	Item
141	Volume 2, number 1 Implementing QALYs Sponsored by an educational grant from AVENTIS Pharma Add to Reading List Source URL: www.medicine.ox.ac.uk Language: English - Date: 2004-01-01 13:10:14 Chemistry Cost–utility analysis Quality-adjusted life year Pharmacoeconomics Docetaxel National Institute for Health and Clinical Excellence Cost-effectiveness analysis Smoking cessation Paclitaxel Health economics Health Medicine
142	European Guidelines for Cost-Effectiveness Assessments of Health Technologies European Consortium in Healthcare Outcomes and Cost-Benefit Research* Health technology assessment (HTA) is becoming more challenging given t Add to Reading List Source URL: www.echoutcome.eu Language: English - Date: 2014-06-06 03:52:40 Costs Evaluation Quality-adjusted life year Cost-effectiveness analysis Health technology assessment Cost–benefit analysis Cost–utility analysis Pharmacoeconomics Health economics Health Medicine
143	The Economics of Health: How do we decide? But is it cost effective? New improved treatment! A new drug, Treatment A, has become available. Preliminary advertising mentions better quality of life and better survival rate Add to Reading List Source URL: motivate.maths.org Language: English - Date: 2011-07-21 13:36:56 Quality-adjusted life year National Institute for Health and Clinical Excellence ICER Cost-effectiveness analysis Cost–utility analysis Health economics Health Medicine
144	HealthEconomics-Answers&Notes-p4 Add to Reading List Source URL: motivate.maths.org Language: English - Date: 2011-08-19 11:04:52 National Institute for Health and Clinical Excellence Quality-adjusted life year Cost-effectiveness analysis National Health Service Cost–utility analysis Pharmacoeconomics Health economics Health Medicine
145	The Economics of Health: How do we decide? Which Treatment? Suppose a serious illness is currently treated with Drug X. Drug X works, but on average patients need to take it for a period of about 2 years in order to be f Add to Reading List Source URL: motivate.maths.org Language: English - Date: 2011-05-25 07:12:30 Quality-adjusted life year National Institute for Health and Clinical Excellence ICER Cost-effectiveness analysis Cost–utility analysis Pharmacoeconomics Health economics Health Medicine
146	Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Quality-adjusted life year Visual prosthesis Cost–utility analysis Retinal Degeneration Retinitis pigmentosa Incremental cost-effectiveness ratio Pharmacoeconomics Macular degeneration Retina Health Medicine Health economics
147	Koerber et al. BMC Health Services Research 2014, 14:163 http://www.biomedcentral.com[removed] RESEARCH ARTICLE Open Access Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Prostatectomy Urinary retention Benign prostatic hyperplasia Prostate-specific antigen Erectile dysfunction Comorbidity Quality-adjusted life year Cost–utility analysis Incremental cost-effectiveness ratio Medicine Health economics Prostate cancer
148	UK DRAFFT - A randomised controlled trial of percutaneous fixation with kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Quality-adjusted life year Cost–utility analysis Incremental cost-effectiveness ratio Knee replacement Orthopedic surgery Cost-effectiveness analysis Unicompartmental knee arthroplasty Open access Osteoarthritis Medicine Health Health economics
149	1675 EXTENDED REPORT Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Quality-adjusted life year Pharmacoeconomics Cataract National Institute for Health and Clinical Excellence Incremental cost-effectiveness ratio Cost-effectiveness analysis Randomized controlled trial Cost–utility analysis Himalayan Cataract Project Health economics Health Medicine
150	Actuaries T h e m ag a z i n e o f t h e Ac t ua r i e s I n s t i t u t e Add to Reading List Source URL: www.actuaries.asn.au Language: English - Date: 2013-06-20 00:29:47 Insurance Actuarial science Bevacizumab Actuary Quality-adjusted life year Cost–utility analysis Actuaries Institute Cetuximab Institute of Actuaries Medicine Health Health economics

UPDATE